Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2022 16:01 ET | Source: Prometheus Biosciences

Prometheus Biosciences Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Progress

- Advanced and expanded development of PRA023 across three immune-mediated indications - - Topline results from ARTEMIS-UC and APOLLO-CD Phase 2 studies on track for fourth quarter 2022 - -...